New Israeli Shekels
|
||||||||||||||||
Year ended December 31, 2017*
|
||||||||||||||||
In millions
|
||||||||||||||||
Cellular segment
|
Fixed-line segment
|
Elimination
|
Consolidated
|
|||||||||||||
Segment revenue - Services
|
1,960
|
622
|
2,582
|
|||||||||||||
Inter-segment revenue - Services
|
18
|
155
|
(173
|
)
|
||||||||||||
Segment revenue - Equipment
|
610
|
76
|
686
|
|||||||||||||
Total revenues
|
2,588
|
853
|
(173
|
)
|
3,268
|
|||||||||||
Segment cost of revenues - Services
|
1,470
|
613
|
2,083
|
|||||||||||||
Inter-segment cost of revenues- Services
|
154
|
19
|
(173
|
)
|
||||||||||||
Segment cost of revenues - Equipment
|
490
|
54
|
544
|
|||||||||||||
Cost of revenues
|
2,114
|
686
|
(173
|
)
|
2,627
|
|||||||||||
Gross profit
|
474
|
167
|
641
|
|||||||||||||
Operating expenses (3)
|
367
|
98
|
465
|
|||||||||||||
Income with respect to settlement agreement with Orange
|
108
|
108
|
||||||||||||||
Other income, net
|
29
|
2
|
31
|
|||||||||||||
Operating profit
|
244
|
71
|
315
|
|||||||||||||
Adjustments to presentation of segment
|
||||||||||||||||
Adjusted EBITDA
|
||||||||||||||||
–Depreciation and amortization
|
445
|
135
|
||||||||||||||
–Other (1)
|
21
|
1
|
||||||||||||||
Segment Adjusted EBITDA (2)
|
710
|
207
|
New Israeli Shekels
|
||||
Year ended
December 31,
2017*
|
||||
In millions
|
||||
Reconciliation of segments subtotal Adjusted EBITDA to profit for the year
|
||||
Segments subtotal Adjusted EBITDA (2)
|
917
|
|||
Depreciation and amortization
|
(580
|
)
|
||
Finance costs, net
|
(180
|
)
|
||
Income tax expenses
|
(21
|
)
|
||
Other (1)
|
(22
|
)
|
||
Profit for the year
|
114
|
New Israeli Shekels
|
||||||||||||||||
Year ended December 31, 2016
|
||||||||||||||||
In millions
|
||||||||||||||||
Cellular segment
|
Fixed-line segment
|
Elimination
|
Consolidated
|
|||||||||||||
Segment revenue - Services
|
2,080
|
672
|
2,752
|
|||||||||||||
Inter-segment revenue - Services
|
19
|
194
|
(213
|
)
|
||||||||||||
Segment revenue - Equipment
|
729
|
63
|
792
|
|||||||||||||
Total revenues
|
2,828
|
929
|
(213
|
)
|
3,544
|
|||||||||||
Segment cost of revenues - Services
|
1,659
|
617
|
2,276
|
|||||||||||||
Inter-segment cost of revenues- Services
|
192
|
21
|
(213
|
)
|
||||||||||||
Segment cost of revenues - Equipment
|
596
|
52
|
648
|
|||||||||||||
Cost of revenues
|
2,447
|
690
|
(213
|
)
|
2,924
|
|||||||||||
Gross profit
|
381
|
239
|
620
|
|||||||||||||
Operating expenses (3)
|
571
|
118
|
689
|
|||||||||||||
Income with respect to settlement agreement with Orange
|
217
|
217
|
||||||||||||||
Other income, net
|
41
|
4
|
45
|
|||||||||||||
Operating profit
|
68
|
125
|
193
|
|||||||||||||
Adjustments to presentation of segment
|
||||||||||||||||
Adjusted EBITDA
|
||||||||||||||||
–Depreciation and amortization
|
447
|
148
|
||||||||||||||
–Other (1)
|
47
|
(1
|
)
|
|||||||||||||
Segment Adjusted EBITDA (2)
|
562
|
272
|
New Israeli Shekels
|
||||
Year ended
December 31, 2016
|
||||
In millions
|
||||
Reconciliation of segments subtotal Adjusted EBITDA to profit for the year
|
||||
Segments subtotal Adjusted EBITDA (2)
|
834
|
|||
Depreciation and amortization
|
(595
|
)
|
||
Other (1)
|
(46
|
)
|
||
Finance costs, net
|
(105
|
)
|
||
Income tax expenses
|
(36
|
)
|
||
Profit for the year
|
52
|
New Israeli Shekels
|
||||||||||||||||
Year ended December 31, 2015
|
||||||||||||||||
In millions
|
||||||||||||||||
Cellular segment
|
Fixed-line segment
|
Elimination
|
Consolidated
|
|||||||||||||
Segment revenue - Services
|
2,275
|
717
|
2,992
|
|||||||||||||
Inter-segment revenue - Services
|
22
|
189
|
(211
|
)
|
||||||||||||
Segment revenue - Equipment
|
1,051
|
68
|
1,119
|
|||||||||||||
Total revenues
|
3,348
|
974
|
(211
|
)
|
4,111
|
|||||||||||
Segment cost of revenues - Services
|
1,856
|
736
|
(*)
|
2,592
|
||||||||||||
Inter-segment cost of revenues- Services
|
187
|
24
|
(211
|
)
|
||||||||||||
Segment cost of revenues - Equipment
|
832
|
48
|
880
|
|||||||||||||
Cost of revenues
|
2,875
|
808
|
(211
|
)
|
3,472
|
|||||||||||
Gross profit
|
473
|
166
|
639
|
|||||||||||||
Operating expenses (3)
|
506
|
134
|
(*)
|
640
|
||||||||||||
Income with respect to settlement agreement with Orange
|
61
|
61
|
||||||||||||||
Other income, net
|
44
|
3
|
47
|
|||||||||||||
Operating profit
|
72
|
35
|
107
|
|||||||||||||
Adjustments to presentation of segment
|
||||||||||||||||
Adjusted EBITDA
|
||||||||||||||||
–Depreciation and amortization
|
||||||||||||||||
(including impairment charges, see note 13)
|
510
|
243
|
||||||||||||||
–Other (1)
|
15
|
1
|
||||||||||||||
Segment Adjusted EBITDA (2)
|
597
|
279
|
New Israeli Shekels
|
||||
Year ended
December 31, 2015
|
||||
In millions
|
||||
Reconciliation of segments subtotal Adjusted EBITDA to loss for the year
|
||||
Segments subtotal Adjusted EBITDA (2)
|
876
|
|||
Depreciation and amortization (including impairment charges, see note 13)
|
(753
|
)
|
||
Other (1)
|
(16
|
)
|
||
Finance costs, net
|
(143
|
)
|
||
Income tax expenses
|
(4
|
)
|
||
Loss for the year
|
(40
|
)
|
(1) |
Mainly amortization of employee share based compensation.
|
(2) |
Adjusted EBITDA as reviewed by the CODM represents Earnings Before Interest (finance costs, net), Taxes, Depreciation and Amortization (including amortization of intangible assets, deferred expenses-right of use and impairment charges) and Other expenses (mainly amortization of share based compensation). Adjusted EBITDA is not a financial measure under IFRS and may not be comparable to other similarly titled measures for other companies. Adjusted EBITDA may not be indicative of the Group's historic operating results nor is it meant to be predictive of potential future results. The usage of the term "Adjusted EBITDA" is to highlight the fact that the Amortization includes amortization of deferred expenses – right of use and amortization of employee share based compensation and impairment charges; it is fully comparable to EBITDA information which has been previously provided for prior periods.
|
(3) |
Operating expenses include selling and marketing expenses and general and administrative expenses.
|